Literature DB >> 27993257

[Depression and Anxiety Disorders and Associated Factors in the Adult Colombian Population, 2015 National Mental Health Survey].

Carlos Gómez-Restrepo1, Nathalie Tamayo Martínez2, Adriana Bohórquez3, Martín Rondón4, Mauricio Medina Rico5, Hernet Rengifo6, Nubia Bautisa7.   

Abstract

INTRODUCTION: Mental disorders are the first causes of disability adjusted life years (DALY), contributing with the 7.4%. This value increases as the DALYs of the transmittable diseases decrease.
OBJECTIVES: To determine the prevalence and associated factors of the major depressive and anxious disorders.
METHODS: Data obtained from the IV Mental Health Survey with representation from 5 regions. A computerised interview was conducted, focusing on the most frequent anxiety and depressive disorders, using the CIDI CAPI 3.0. A sample of 10,870 adults over 18 years old was obtained.
RESULTS: The lifetime prevalence of any of these disorders is 10.1% (95% CI: 8.8-11.5) in the population between 18 and 44 years, and of 7.7% (95% CI: 6.5-9.1) in those older than 45 years. The prevalence in the last 12 months was 5.1% (95% CI: 4.3-6.0) in the younger group, and 2.3% (95% CI: 1.8-3.0) in the older group. Of the people with evaluated mental disorders, 17.6% (95% CI: 13.1-23.4) had 2 or more disorders, a comorbidity that is more common in the female population (20.4%, 95% CI: 14.2-28.3) than in males (13.5%, 95% CI: 7.9-22.0). Major depressive disorder is the most prevalent of the disorders, with a lifetime prevalence of 4.3% (95% CI: 3.7-5.0). After adjusting in a multivariate model, being divorced or widowed (OR=1.3), previous suicide attempt (OR=3.3), and having 6 or more features of border-line personality, were associated with an increased risk of presenting with any of the studied disorders.
CONCLUSIONS: Anxiety and depressive mental disorders are an important health burden in Colombia.
Copyright © 2016. Publicado por Elsevier España.

Entities:  

Keywords:  Anxiety disorders; Depresión; Depression; Encuestas epidemiológicas; Epidemiological surveys; Mental disorders; Trastornos de ansiedad; Trastornos mentales

Mesh:

Year:  2016        PMID: 27993257     DOI: 10.1016/j.rcp.2016.04.009

Source DB:  PubMed          Journal:  Rev Colomb Psiquiatr        ISSN: 0034-7450


  5 in total

1.  Implementing Technology-Supported Care for Depression and Alcohol Use Disorder in Primary Care in Colombia: Preliminary Findings.

Authors:  William C Torrey; Magda Cepeda; Sergio Castro; Sophia M Bartels; Leonardo Cubillos; Fernando Suárez Obando; Pablo Martínez Camblor; José Miguel Uribe-Restrepo; Makeda Williams; Carlos Gómez-Restrepo; Lisa A Marsch
Journal:  Psychiatr Serv       Date:  2020-03-10       Impact factor: 3.084

2.  Effect of the COVID-19 pandemic on the mental health, daily and occupational activities of otolaryngologists and allergists in Colombia: a national study.

Authors:  Lucia C Pérez-Herrera; Sergio Moreno-López; Daniel Peñaranda; Irene C Pérez-García; Elizabeth García; Gloria Corredor-Rojas; Edgardo Chapman; Augusto Peñaranda
Journal:  Int Forum Allergy Rhinol       Date:  2021-06-08       Impact factor: 5.426

3.  Prevalence and Factors Associated with Burnout Syndrome in Colombian Anesthesiologists.

Authors:  Javier Eslava-Schmalbach; Nathaly Garzón-Orjuela; Nathalie Tamayo Martínez; Lina Gonzalez-Gordon; Eric Rosero; Carlos Gómez-Restrepo
Journal:  Int J Prev Med       Date:  2020-01-24

4.  Scaling Up Science-Based Care for Depression and Unhealthy Alcohol Use in Colombia: An Implementation Science Project.

Authors:  Lisa A Marsch; Carlos Gómez-Restrepo; Sophie M Bartels; Kathleen Bell; Pablo Martinez Camblor; Sergio Castro; Maria Paula Cárdenas Charry; Magda Cepeda; Leonardo Cubillos; Deepak John; Maria Paula Jassir; Shea M Lemley; Fernando Suárez-Obando; William C Torrey; José Miguel Uribe; Makeda J Williams
Journal:  Psychiatr Serv       Date:  2021-08-04       Impact factor: 3.084

5.  Trends in the prevalence and treatment of depressive symptoms in Peru: a population-based study.

Authors:  David Villarreal-Zegarra; Milagros Cabrera-Alva; Rodrigo M Carrillo-Larco; Antonio Bernabe-Ortiz
Journal:  BMJ Open       Date:  2020-07-19       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.